Patents Examined by Robert S Cabral
  • Patent number: 11560014
    Abstract: The present invention is directed to methods for inhibiting growth of bacteria and to nanometer scale surfaces having antibacterial properties.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: January 24, 2023
    Assignee: Brown University
    Inventor: Thomas J. Webster
  • Patent number: 11559494
    Abstract: In one aspect, compositions are described herein. A composition described herein comprises a nanoparticle, a therapeutic species, and a linker joining the nanoparticle to the therapeutic species. The linker joining the nanoparticle to the therapeutic species comprises a Diels-Alder cyclo-addition reaction product. Additionally, in some embodiments, the nanoparticle is a magnetic nanoparticle.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: January 24, 2023
    Assignee: THE PENN STATE RESEARCH FOUNDATION
    Inventors: Daniel J Hayes, Mohammad Abu-Laban
  • Patent number: 11541062
    Abstract: Provided herein are methods for treating metastatic prostate cancer using anti-androgen compounds and radionuclide-labeled androgens.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: January 3, 2023
    Assignee: CITY OF HOPE
    Inventors: Zijie Sun, David Horne, Junfeng Li, John E. Shively, Jun Xie
  • Patent number: 11534114
    Abstract: The present invention provides 18F-labeled amino acids or derivatives thereof having formula (I) and methods of making same, which can be suitable for PET imaging:
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: December 27, 2022
    Assignee: Simon Fraser University
    Inventors: Paul Schaffer, Hua Yang, Robert Britton, Matthew Nodwell, Zheliang Yuan
  • Patent number: 11529440
    Abstract: Embodiments of the invention include drug delivery coatings and devices including the same. In an embodiment, the invention includes a drug delivery coating including a polymeric layer. The polymeric layer can include a hydrophilic outer surface. The coating can also include a matrix contacting the hydrophilic outer surface. The matrix can include a particulate hydrophobic therapeutic agent and a cationic agent. The polymeric layer can further include a hydrophilic polymer having pendent photoreactive groups and a photo-crosslinker including two aryl ketone functionalities. Other embodiments are also included herein.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: December 20, 2022
    Assignee: Surmodics, Inc.
    Inventors: Joram Slager, Toni M. Heyer, David E. Babcock
  • Patent number: 11529317
    Abstract: There is provided a method of preparing silica nanocapsules, the method comprising mixing a surfactant with water at a temperature that is above the gel-to-liquid transition temperature of the surfactant to form a mixture, passing the mixture one or more times through at least one pore to obtain a dispersion of vesicles, and adding a silica precursor to the dispersion of vesicles to form silica nanocapsules. Also provided is a silica nanocapsule formed from a vesicle template, and a method of delivering one or more types of molecules to a subject. In a specific embodiment, hollow silica nanocapsules having substantially lens-shaped are synthesized by employing dimethyldioctadecylammonium bromide (DODAB) or dioctadecyldimethyl ammonium chloride (DODAC) as the vesicle template and tetraethyl orthosilicate (TEOS) as the silica precursor.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: December 20, 2022
    Assignee: Agency for Science, Technology and Research
    Inventors: Eun Ju Park, Alexander M. Van Herk, Praveen Thoniyot
  • Patent number: 11524082
    Abstract: The present disclosure relates to compositions and methods of carbonic anhydrase IX inhibitors. The present disclosure also relates to targeting conjugates of carbonic anhydrase IX inhibitors. The present disclosure also relates to the use of targeting conjugates of carbonic anhydrase IX inhibitors in methods of treating disease and for imaging of disease.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: December 13, 2022
    Assignee: Purdue Research Foundation
    Inventors: Philip S. Low, Isaac J. Marks, Spencer Gardeen, Sumith A. Kularatne
  • Patent number: 11497726
    Abstract: Disclosed are methods useful for the topical therapeutic treatment of cervical intraepithelial neoplasia (CIN) and/or cervical cancer using compositions containing nanoparticles of paclitaxel or other taxanes.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: November 15, 2022
    Assignee: DFB SORIA, LL.
    Inventor: Gere Dizerega
  • Patent number: 11497717
    Abstract: The present invention relates to the medical field, in particular to the treatment of neurological disorders. More specifically the present invention relates to a nanoparticle or nanoparticles' aggregate for use in prevention or treatment of a neurological disease or at least one symptom thereof in a subject without exposure of the nanoparticle or nanoparticles' aggregate to an electric field, and preferably without exposure thereof to any other external activation source, wherein the nanoparticle's or nanoparticles' aggregate's material is selected from a conductor material, a semiconductor material, an insulator material with a dielectric constant ?ijk equal to or above 200, and an insulator material with a dielectric constant ?ijk equal to or below 100.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: November 15, 2022
    Assignee: NANOBIOTIX S.A.
    Inventors: Marie-Edith Meyre, Laurent Levy, Agnès Pottier
  • Patent number: 11492256
    Abstract: The invention generally relates to compositions of hypochlorous acid (HOCl) and methods of manufacture thereof. In certain aspects, the invention provides air-free compositions of HOCl. In other aspects, the invention provides methods of making HOCl that involve mixing together in water in an air-free environment, a compound that generates a proton (H+) in water and a compound that generates a hypochlorite anion (OCl?) in water to thereby produce air-free hypochlorous acid.
    Type: Grant
    Filed: February 19, 2020
    Date of Patent: November 8, 2022
    Assignee: WIAB WATER INNOVATION AB
    Inventors: Geir Hermod Almås, Adrian Bignami
  • Patent number: 11484549
    Abstract: Disinfecting compositions containing hypochlorous acid and acetic acid are useful for treating biofilms in or on tissue, including biofilms related to wounds or other skin trauma. The compositions are useful for treating a variety of types of tissue, both on the surface on beneath the surface of tissue. Compositions are provided for treating biofilms without inducing antimicrobial resistance.
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: November 1, 2022
    Assignee: WIAB WATER INNOVATION AB
    Inventor: Geir Hermod Almås
  • Patent number: 11484500
    Abstract: The present invention provides a hybrid biocompatible carrier (hybridosome) which comprises structural and bioactive elements originating from at least one biocompatible delivery module (BDM) and at least one engineered drug encapsulation module (EDEM) comprising at least one tunable fusogenic moiety. The invention further provides pharmaceutical compositions comprising said hybridosomes, processes for their manufacture, as well as pharmaceutical uses and pharmaceutical methods based thereon.
    Type: Grant
    Filed: January 2, 2020
    Date of Patent: November 1, 2022
    Assignee: ANJARIUM BIOSCIENCES AG
    Inventor: Joel De Beer
  • Patent number: 11478557
    Abstract: A method of preparing a radioactive yttrium phosphate particle suspension.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: October 25, 2022
    Assignee: Vivos, Inc.
    Inventors: Michael Korenko, David Swanberg
  • Patent number: 11471541
    Abstract: Provided is use of miR-21 in preparation of a therapeutic drug or diagnostic reagent for intrauterine adhesion and/or thin endometrium.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: October 18, 2022
    Assignee: NANJING DRUM TOWER HOSPITAL
    Inventors: Yali Hu, Yan Zhou, Guangfeng Zhao, Ruotian Li
  • Patent number: 11471482
    Abstract: The present invention relates to the medical field, in particular to the enhancement of brain performances and for the treatment of pathological stress. More specifically the present invention relates to a nanoparticle or nanoparticles' aggregate for use in enhancing brain performances or in prevention or treatment of pathological stress in a subject without exposure of the nanoparticle or nanoparticles' aggregate to an electric field, and preferably without exposure thereof to any other external activation source, wherein the nanoparticle's or nanoparticles' aggregate's material is selected from a conductor material, a semiconductor material, an insulator material with a dielectric constant ?ijk equal to or above (200), and an insulator material with a dielectric constant ?ijk equal to or below (100).
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: October 18, 2022
    Assignee: NANOBIOTIX S.A.
    Inventors: Agnès Pottier, Laurent Levy, Marie-Edith Meyre
  • Patent number: 11471543
    Abstract: The present invention relates to stable pharmaceutical compositions of sulfur colloid, which advantageously provide a high radiochemical purity to 99mTc-pertechnetate without causing the gel formation. The compositions include pre-lyophilized and lyophilized compositions of sulfur colloid. It also relates to a non-radioactive kit which upon reconstitution with 99mTc-pertechnetate solution gives stabilized 99mmTc-Sulfur colloid radiopharmaceutical composition. Further, the process for preparation of said compositions and their use for diagnostic purposes are also disclosed.
    Type: Grant
    Filed: October 7, 2019
    Date of Patent: October 18, 2022
    Inventors: Harmik Sohi, Rahul Hasija, Basant Malik, Kamal S. Mehta, Dinesh Kumar
  • Patent number: 11471421
    Abstract: The present invention provides an improved process for preparing microparticles containing glatiramer acetate having low levels of residual organic solvent(s), in particular dichloromethane. The microparticles are incorporated into long acting parenteral pharmaceutical compositions in depot form that are suitable for subcutaneous or intramuscular implantation or injection, and that may be used to treat multiple sclerosis.
    Type: Grant
    Filed: August 28, 2017
    Date of Patent: October 18, 2022
    Assignee: MAPI PHARMA LTD.
    Inventors: Nadav Bleich Kimelman, Shai Rubnov, Ehud Marom
  • Patent number: 11459569
    Abstract: The present invention is inserted in the fields of nanotechnology, pharmacy and genetics and refers to specific sequences of interference RNA (siRNA), capable of silencing the gene responsible for the expression of an adhesion protein, which produces overexpressed extracellular adenosine in tumors, the enzyme ecto-5?-nucleotidase/CD73 (CD73). The specific siRNA sequences for CD73 are proposed in a nanometer scale composition in the form of liposomes or nanoemulsions in order to promote a site-directed release complex capable of being incorporated into several types of formulation, such as intratumor, intravenous injection or administration nasal. The siRNA sequences to silence CD73 can also be applied in the manufacture of kits and/or in silencing tests of CD73 for scientific research using liposomes, nanoemulsions or other transfection reagents.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: October 4, 2022
    Inventors: Elizandra Braganhol, Ana Maria Oliveira Battastini, Helder Teixeira, Marco Antônio Stefani, Fernanda Bruxel, Roselia Maria Spanevello, Fernanda Cardoso Teixeira, Juliana Hofstatter Azambuja
  • Patent number: 11452741
    Abstract: Disinfecting compositions containing hypochlorous acid and acetic acid are useful for treating transient biofilms in or on tissue without harming the natural flora of the tissue. The compositions are useful for treating a variety of types of tissue. Compositions are useful for treating and preventing orally-associated biofilm. Compositions may be provided in mouthwash form, spray form, gel form, cream form, dentifrice form, and may include nanoparticle encapsulated molecules for controlled release.
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: September 27, 2022
    Assignee: WIAB WATER INNOVATION AB
    Inventor: Geir Hermod Almås
  • Patent number: 11452777
    Abstract: The present invention discloses a method for synthesizing a new ferrihydrite nano-photosensitizer, comprising steps of: weighing 303 mg of Fe(NO3)3?9H2O solid dissolved fully in 30 ml of distilled water to prepare a 0.75 mM of Fe(NO3)3 solution in water; adding PEG solid to the solution in water by stirring to fully dissolve at a molar ratio of PEG to Fe3+ of 1:1-1:50; stirring the obtained solution under heating at 75° C. in a water bath for 10-50 minutes, and then immediately cooling in an ice bath after removing; centrifuging and washing the cooled mixed solution at high speed under low temperature with the supernatant discarded, to obtain pellets as PEG-modified ferrihydrite nanoparticles (PEG-Fns). The PEG-Fns synthesized in the present invention can be controllably induced and reduced by blue light to release Fe2+, and then produce ?OH through Fenton reaction of Fe2+ and H2O2 in the cell, which induces cell oxidative damage, thereby achieving controllable anticancer and antibacterial purposes.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: September 27, 2022
    Inventors: Lianbing Zhang, Yingchun Yang, Qing Tian, Aipeng Li, Yao Chen